cyclophilin D inhibitors (EMD Serono/Merck KGaA/Edelris/Syngene)

N/A

Report date: 2025/01/26 18:21:46
NME

Base Information

Drug Namecyclophilin D inhibitors (EMD Serono/Merck KGaA/Edelris/Syngene)
Drug Alias NameMSC-2530594
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin D inhibitors
TargetsCyclophilin D
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFranceIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesSyngene International LtdEdelris SASMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A